跳至主要内容
临床试验/NCT06039306
NCT06039306招募中不适用

Perioperative Immunonutrition Among Gynecological Cancer Patients Under Enhanced Recovery After Surgery

Universiti Putra Malaysia1 个研究点 分布在 1 个国家目标入组 106 人开始时间: 2024年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
106
试验地点
1
主要终点
postoperative outcomes

研究概览

简要总结

The goal of this clinical trial is to compare the effect of perioperative immunonutrition supplement in gynecologic cancer patients. The main questions it aims to answer are:

  • is there any difference in the nutritional outcomes and functional outcomes between intervention and conventional groups?
  • is there any difference in the post-surgical outcomes between intervention and conventional groups?

Participants (intervention) will be provided the immunonutrition supplement before and after operation.

Researchers will compare intervention group with conventional group to see if there is any difference in postoperative outcomes.

详细描述

The clinical trial aims to determine the effectiveness of perioperative IMN intervention on postoperative outcomes among GC patients under Enhanced Recovery after Surgery (ERAS) setting. Patients will prescribed with immunonutrition supplement before and after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Those who diagnosed with GC
  • •Candidates for elective operation treatments

排除标准

  • •Those are involved gastrointestinal tract (complication)
  • •Those are diagnosed with GC (metastasis)
  • •Allergy to milk/soy/whey protein
  • •Participate in other intervention study

研究组 & 干预措施

intervention

Experimental

Participants will be given 2 servings immunonutrition daily for five (5) days before tentative elective surgery. ERAS protocol will implement and continued 2 servings of immunonutrition for post-operative seven (7) days.

干预措施: Immunonutrition oral nutrition supplementation (Dietary Supplement)

conventional

No Intervention

Participants will be on usual diet intake before tentative elective surgery. ERAS protocol will implement and will be prescribed 2 servings of polymeric formula daily only if unable to finish 75% of the diet served in ward.

结局指标

主要结局

postoperative outcomes

时间窗: 1 months

length of hospitalization

body composition

时间窗: 1 month

body composition analyzer; weight in kg; fat free mass in kg; fat mass in kg; muscle mass in kg; height in meter

daily energy and protein intake

时间窗: 1 month

24-hours diet recall

immunoglobulin level

时间窗: 1 month

Concentration of immunoglobulin G; Concentration of immunoglobulin A; Concentration of immunoglobulin M

C-reactive protein

时间窗: 1 month

Concentration of C-reactive protein

次要结局

  • stress level(1 month)
  • Functional status(1 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

ChiouYi Ho

Principal Investigator

Universiti Putra Malaysia

研究点 (1)

Loading locations...

相似试验

Perioperative Immunonutrition Under Enhanced... | 临床试验